Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Enfusion Q3 Sales $29.00M Beat $26.72M Estimate

Enfusion (NYSE:ENFN) reported quarterly sales of $29.00 million which beat the analyst consensus estimate of $26.72 million by 8.53 percent.

byBenzinga Newsdesk

December 2, 2021

1 minute read

Enfusion (NYSE:ENFN) reported quarterly sales of $29.00 million which beat the analyst consensus estimate of $26.72 million by 8.53 percent.

AMD, Tilray Brands And 3 Stocks To Watch Heading Into Friday

By Lisa Levin

Today, 6:29 AM

With US stock futures trading mixed this morning on Friday, some of the stocks that may grab investor focus today are as follows:

AEHR

Tyler Technologies Extends Contract For Digital Government And Payment Solutions In Vermont

By Benzinga Newsdesk

Today, 6:29 AM

hree-year extension adds to existing 16-year relationship with the state Tyler Technologies, Inc. (NYSE:TYL) recently announced that the state of Vermont has extended its contract for Tyler's award-winning

TYL

Canadian Pacific Inks Multi-Year Deal With CMA CGM

By Akanksha Bakshi

Today, 6:29 AM

Canadian Pacific Railway Ltd (NYSE: CP) (TSX: CP) established

Wells Fargo Maintains Equal-Weight on Coupa Software, Lowers Price Target to $190

By Benzinga Newsdesk

Today, 6:29 AM

Wells Fargo analyst Michael Turrin maintains Coupa Software (NASDAQ:COUP) with a Equal-Weight and lowers the price target from $270 to $190.

COUP

Enfusion Q3 Sales $29.00M Beat $26.72M Estimate

Related Posts

AMD, Tilray Brands And 3 Stocks To Watch Heading Into Friday

Tyler Technologies Extends Contract For Digital Government And Payment Solutions In Vermont

Canadian Pacific Inks Multi-Year Deal With CMA CGM

Wells Fargo Maintains Equal-Weight on Coupa Software, Lowers Price Target to $190